COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,610 Articles (22,913 medRxiv, 8,697 bioRxiv)

Most recent first Previous |  Page 1297: Articles 12961-12970  | Next

Heterologous prime-boost immunization with CoronaVac and Convidecia
Li, J., Hou, L., Guo, X., Jin, P., Wu, S., Zhu, J., Pan, H., Wang, X., Song, Z., Wan, J., Cui, L., Li, J., Wang, X., Jin, L., Liu, J., Shi, F., Xu, X., Chen, Y., Zhu, T., Chen, W., Zhu, F.
10.1101/2021.09.03.21263062 — Posted: 2021-09-06 Discussion: Onsite
A semi-parametric, state-space compartmental model with time-dependent parameters for forecasting COVID-19 cases, hospitalizations, and deaths
O'Dea, E. B., Drake, J. M.
10.1101/2021.09.02.21262995 — Posted: 2021-09-06
UTTARAKHAND COVID-19 CASES AND DEATHS: COMPARING THE DEMOGRAPHICS AND SUGGESTIVE STRATEGY TO PREVENT SIMILAR PANDEMICS IN FUTURE
Joshi, G., Pande, A., Gupta, O., Nautiyal, A., Jasola, S., Gahtori, P.
10.1101/2021.09.03.21263064 — Posted: 2021-09-06
The missing microbes: Bifidobacterium and Faecalibacterium depletion and loss of microbiome diversity as potential susceptibility markers for SARS-CoV-2 infection and severity
Hazan, S., Stollman, N., Bozkurt, H. S., Dave, S., Papoutsis, A. J., Daniels, J., Dolai, S., Barrows, B. D., Quigley, E. M., Borody, T. J.
10.1101/2021.09.02.21262832 — Posted: 2021-09-06
Local SARS-CoV-2 peptide-specific Immune Responses in Convalescent and Uninfected Human Lung Tissue Models
Goliwas, K. F., Simmons, C. S., Khan, S. A., Wood, A. M., Wang, Y., Berry, J. L., Athar, M., Mobley, J. A., Kim, Y.-i., Thannickal, V. J., Harrod, K. S., Donahue, J. M., Deshane, J. S.
10.1101/2021.09.02.21263042 — Posted: 2021-09-06
Association between City-wide Lockdown and COVID-19 Hospitalization Rates in Multigenerational Households in New York City
Ghosh, A. K., Venkataraman, S., Reshetnyak, E., Rajan, M., An, A., Chae, J. K., Unruh, M. A., Abramson, D., DiMaggio, C. K., Hupert, N.
10.1101/2021.08.31.21262914 — Posted: 2021-09-06 Discussion: Onsite
Functional respiratory capacity in the elderly after COVID-19 -- a pilot study
Pereira, F. A., Tomas, M. T.
10.1101/2021.09.03.21263076 — Posted: 2021-09-06
COVID-19 Vaccine Efficacy in a Diverse Urban Healthcare Worker Population
Iliaki, E., Lan, F.-Y., Christophi, C. A., Guidotti, G., Jobrack, A. D., Buley, J., Nathan, N., Osgood, R., Bruno-Murtha, L. A., Kales, S. N.
10.1101/2021.09.02.21263038 — Posted: 2021-09-06
Long COVID: Assessment of Neuropsychiatric Symptoms in Children and Adolescents - A Clinical Data Analysis
Froelich, J., Banaschewski, T., Ulmer, A.
10.1101/2021.09.03.21257002 — Posted: 2021-09-06
Secondary transmission of SARS-CoV-2 in educational settings in Northern Italy from September 2020 to April 2021: a population-based study
Djuric, O., Larosa, E., Cassinadri, M., Cilloni, S., Bisaccia, E., Pepe, D., Vicentini, M., Venturelli, F., Bonvicini, L., Giorgi Rossi, P., Pezzotti, P., Mateo Urdiales, A., Bedeschi, E., Reggio Emilia Covid-19 Working Group
10.1101/2021.09.03.21263061 — Posted: 2021-09-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).